Publications by authors named "Toru Dejima"

Claim this Profile
T
Time course of restenosis with "black hole" on intravascular ultrasound after implantation of platinum-chromium everolimus-eluting stent: Assessment using optical frequency-domain imaging.
Shinnosuke Kikuchi, Yukiko Morita, Masahiko Kanna, Toru Dejima, Mina Nakayama

J Cardiol Cases· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible combinatorial effects of current smoking and alcohol intake on chronic kidney disease in a Japanese nationwide cross-sectional survey.
Kouichi Tamura, Toru Dejima, Yukiko Morita, Satoshi Hirade, Hiromichi Wakui

Hypertens Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2).
Kengo Azushima, Kouichi Tamura, Sona Haku, Hiromichi Wakui, Tomohiko Kanaoka, Toru Dejima

Atherosclerosis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Hiromichi Wakui, Kazushi Uneda, Kouichi Tamura, Masato Ohsawa, Kengo Azushima, Toru Dejima

J Am Heart Assoc· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.
Kengo Azushima, Kazushi Uneda, Kouichi Tamura, Hiromichi Wakui, Masato Ohsawa, Toru Dejima

Biomed Res Int· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders.
Akinobu Maeda, Kouichi Tamura, Hiromichi Wakui, Masato Ohsawa, Kengo Azushima, Toru Dejima

Int J Med Sci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.
Masato Ohsawa, Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Toru Dejima

Kidney Int· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity.
Kengo Azushima, Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Masato Ohsawa, Toru Dejima

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Hiromichi Wakui, Toru Dejima, Kouichi Tamura, Kazushi Uneda, Koichi Azuma

Cardiovasc Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Toru Dejima, Masato Ohsawa

Curr Pharm Des· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.
Masato Ohsawa, Kouichi Tamura, Tomohiko Kanaoka, Hiromichi Wakui, Akinobu Maeda, Toru Dejima

Int J Mol Sci· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Akinobu Maeda, Kouichi Tamura, Hiromichi Wakui, Toru Dejima, Masato Ohsawa

J Am Heart Assoc· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease.
Kouichi Tamura, Tomohiko Kanaoka, Masato Ohsawa, Sona Haku, Kengo Azushima, Toru Dejima

Am J Cardiovasc Dis· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Akinobu Maeda, Kouichi Tamura, Tomohiko Kanaoka, Masato Ohsawa, Sona Haku, Toru Dejima

Clin Exp Hypertens· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of ambulatory blood pressure and the heart rate profile with renal function parameters in hypertensive patients with chronic kidney disease.
Tomohiko Kanaoka, Kouichi Tamura, Masato Ohsawa, Mai Yanagi, Sona Haku, Toru Dejima

Clin Exp Hypertens· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increase in perfusion pressure and activation of the renin-angiotensin system in the pathogenesis of hypertension and injury: strain vessels and the cerebrovascular-renal connection.
Kouichi Tamura, Akinobu Maeda, Kazushi Uneda, Hiromichi Wakui, Toru Dejima

Hypertens Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients.
Tomohiko Kanaoka, Kouichi Tamura, Masato Ohsawa, Hiromichi Wakui, Akinobu Maeda, Toru Dejima

J Clin Hypertens (Greenwich)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
Tomohiko Kanaoka, Kouichi Tamura, Tatsumi Moriya, Keiji Tanaka, Yusuke Konno, Toru Dejima

Clin Exp Hypertens· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Toru Dejima, Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Masato Ohsawa

J Hypertens· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of Runx3 in the basal transcriptional activation of the mouse angiotensin II type 1 receptor-associated protein gene.
Miyuki Matsuda, Kouichi Tamura, Hiromichi Wakui, Toru Dejima, Akinobu Maeda

Physiol Genomics· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice.
Hiromichi Wakui, Kouichi Tamura, Miyuki Matsuda, Yunzhe Bai, Toru Dejima

Am J Physiol Renal Physiol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.
Shin-ichiro Masuda, Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Toru Dejima

Am J Physiol Renal Physiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
Hiromichi Wakui, Kouichi Tamura, Yutaka Tanaka, Miyuki Matsuda, Yunzhe Bai, Toru Dejima

Hypertension· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.
Shin-ichiro Masuda, Kouichi Tamura, Hiromichi Wakui, Tomohiko Kanaoka, Masato Ohsawa, Toru Dejima

Hypertens Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure variability as well as blood pressure level is important for left ventricular hypertrophy and brachial-ankle pulse wave velocity in hypertensives.
Motoko Ozawa, Kouichi Tamura, Yasuko Okano, Kouhei Matsushita, Yuko Ikeya, Toru Dejima

Clin Exp Hypertens· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis